Is Hikma Pharmaceuticals the next takeover target in the pharmaceutical sector?
The boys over The Motley Fool certainly seem to think so.
Here is a link to a piece they published this morning outlining why Hikma might be of interest to Mylan, which recently tried to buy Sweden's Meda:
http://www.fool.co.uk/investing/2014/05/06/could-shire-plc-and-hikma-pharmaceuticals-plc-be-the-next-pharma-takeover-targets/?source=isesitlnk0000001&mrr=1.00
No comments:
Post a Comment